Navigation Links
Global E-Clinical Trial Technologies Industry
Date:8/30/2012

NEW YORK, Aug. 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global E-Clinical Trial Technologies Industry

http://www.reportlinker.com/p0960434/Global-E-Clinical-Trial-Technologies-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 80 companies including many key and niche players such as Aris Global, BioClinica, Clinipace Worldwide, Cmed Technology Ltd., DATATRAK International, Inc., DZS Software Solutions, Inc., eResearchTechnology, Inc., Medidata Solutions, Inc., Merge Healthcare, Inc., OmniComm Systems, Inc., Oracle Inc., Phase Forward, Inc., PAREXEL International Corporation, Perceptive Informatics, Inc., PharmaPros Corporation, Prelude Dynamics LLC, SAS Institute Inc., Target Health Inc., and Trianz Solutions. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

 

To order this report:

Drug_Discovery_and_Development Industry: Global E-Clinical Trial Technologies Industry

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Prenatal Diagnostics Industry
2. Global Needle-Free Drug Injection Systems and Safety Syringes Industry
3. Global High Content Screening (HCS) Industry
4. Global RFID in Healthcare and Pharmaceuticals Industry
5. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
6. Hologic To Participate In The Morgan Stanley Global Healthcare Conference
7. Bioquark, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference
8. Watson to Present at the 2012 Bank of America Merrill Lynch Global Healthcare Conference
9. Global Nutraceuticals Industry
10. Global Dental Implants Industry
11. Global Artificial Implants Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from ... performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, and ... important patterns in student test score performance, the report’s limited analyses fail to ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... contracted partners to help with process innovation in drug formulation and manufacturing. ... along with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine ... focus on preventative care with all my patients to alleviate possible future issues. I am ... to contact my office and my trained staff will assist you in any way possible.” ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):